Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Capecitabine × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 18 Stomach Neoplasms 11 Adenocarcinoma Of Esophagus 7 Neoplasm Metastasis 6 Triple Negative Breast Neoplasms 5 Rectal Neoplasms 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Esophageal Neoplasms 5 Colorectal Neoplasms 5 Colonic Neoplasms 3 Adenocarcinoma 3 Pathologic Complete Response 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Gallbladder Neoplasms 2 Cholangiocarcinoma 2 Anus Neoplasms 2 Somatostatinoma 1 Resectable Colon Cancer 1 Recurrence 1 Pancreatic Intraductal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasm, Residual 1 Meningeal Neoplasms 1 Locally Advanced Rectal Cancer With Liver Metastases 1 Locally Advanced Rectal Cancer 1 Klatskin Tumor 1 Insulinoma 1 HIV Infections 1 HER2-positive Gastric Cancer 1

Interventions

Carboplatin 4 Paclitaxel 3 Bevacizumab 3 trastuzumab deruxtecan 1 rucaparib 1 pembrolizumab 1 olaparib 1 niraparib 1 mirvetuximab soravtansine 1 Saline Solution 1 Preoperative Exercise 1 Platinum 1 Nivolumab 1 Hyperthermic Intraperitoneal Chemotherapy 1 Glucose 1 GEN-1 1 Drug Therapy 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡